【结 构 式】 |
【分子编号】11703 【品名】D-Phenylalanine; (R)-Phenylalanine 【CA登记号】673-06-3 |
【 分 子 式 】C9H11NO2 【 分 子 量 】165.19188 【元素组成】C 65.44% H 6.71% N 8.48% O 19.37% |
合成路线1
该中间体在本合成路线中的序号:(VI)The hydrogenation of 4-isopropylbenzoic acid (I) with H2 over PtO2 in acetic acid gives 4-isopropylcyclohexanecarboxylic acid as a mixture of cis- and trans-isomers (II). This mixture is esterified with methanol to the corresponding mixture of methyl esters (III), which is isomerized with NaH at 150 C without solvent, affording the trans-methyl ester (IV). Hydrolysis of (IV) with NaOH in methanol - water gives the free acid (V), which is finally condensed with D-phenylalanine (VI) by means of N-hydroxysuccinimide and dicyclohexylcarbodiimide in chloroform.
【1】 Toyoshima, S.; Seto, Y.; Shinkai, H.; Toi, K.; Kumashiro, I. (Ajinomoto Co., Inc.); Hypoglycemic agent. EP 0196222; US 4816484 . |
【2】 Shinkai, H.; Dan, K.; Toi, K.; Kumashiro, I.; Seto, Y.; Toyoshima, S.; Nishikawa, M.; Fukuma, M.; Sato, Y.; N-(Cyclohexyl)carbonyl-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2. J Med Chem 1989, 32, 7, 1436. |
【3】 Prous, J.; Graul, A.; Castaner, J.; AY-4166. Drugs Fut 1993, 18, 6, 503. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11698 | 4-Isopropylbenzoic acid | 536-66-3 | C10H12O2 | 详情 | 详情 |
(II) | 11699 | 4-Isopropylcyclohexanecarboxylic acid | C10H18O2 | 详情 | 详情 | |
(III) | 11700 | methyl 4-isopropylcyclohexanecarboxylate | C11H20O2 | 详情 | 详情 | |
(IV) | 11701 | methyl 4-isopropylcyclohexanecarboxylate | C11H20O2 | 详情 | 详情 | |
(V) | 11702 | 4-Isopropylcyclohexanecarboxylic acid | C10H18O2 | 详情 | 详情 | |
(VI) | 11703 | D-Phenylalanine; (R)-Phenylalanine | 673-06-3 | C9H11NO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:CP-72467-2 has been prepared by two synthetic routes which share a common intermediate. 1) In the initial route, diazotization of D-phenylalanine followed by esterification afforded the methyl ester of (R)-phenyllactic acid (I). Mitsunobu coupling with methyl 4-hydroxybenzoate using diisopropyl azodicarboxylate, selective reduction with sodium borohydride, and conversion to the bromide by in situ generation of triphenylphosphine dibromide produced intermediate (II). Friedel-Crafts alkylation of (II) using alpha-hydroxyhippuric acid/methanesulfonic acid, azalactone formation with acetic anhydride/triethylamine, followed by in situ spiroalkylation produced the N-benzoyl amino acid (III). Oxidative decarboxylation of (III) with 15% sodium hypochlorite led to the chromanone (V), presumably through hydrolysis of the intermediate N-benzoyl imine (IV). Catalytic hydrogenation over 10% Pd on carbon of the chromanone (V), reduction of the ester with Red-Al, and subsequent oxidation of the alcohol with manganese dioxide afforded the key aldehyde intermediate (VI). Condensation of aldehyde (VI) with 2,4-thiazolidinedione/pyridine, catalytic hydrogenation of the resultant olefin, and salt formation with sodium methoxide produced CP-72467-2. 2) An alternative synthesis of the key intermediate aldehyde (VI) utilizes an enzymatic resolution of the benzopyran ester (VII). Reduction of the 2(R)-ester with sodium borohydride followed by reaction with triflic anhydride generates the triflate (VIII). Copper-catalyzed reaction of the triflate (VIII) with phenyl magnesium bromide afforded the benzyl derivative (IX), which is readily formylated with phosphorous oxychloride/N-methyl formanilide to produce aldehyde (VI).
【1】 Clark, D.A.; Goldstein, S.W.; Volkmann, R.A.; et al.; Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents. J Med Chem 1991, 34, 1, 319. |
【2】 Stevenson, R.W.; Urban, F.J.; Clark, D.A.; Englitazone Sodium. Drugs Fut 1992, 17, 3, 182. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
11703 | D-Phenylalanine; (R)-Phenylalanine | 673-06-3 | C9H11NO2 | 详情 | 详情 | |
((VII)-R) | 13885 | ethyl (2R)-3,4-dihydro-2H-chromene-2-carboxylate | C12H14O3 | 详情 | 详情 | |
(I) | 13878 | methyl (2R)-2-hydroxy-3-phenylpropanoate | C10H12O3 | 详情 | 详情 | |
(II) | 13879 | methyl 4-[[(1S)-1-benzyl-2-bromoethyl]oxy]benzoate | C17H17BrO3 | 详情 | 详情 | |
(III) | 13880 | (2S)-4-(Benzoylamino)-2-benzyl-6-(methoxycarbonyl)-3,4-dihydro-2H-chromene-4-carboxylic acid | C26H23NO6 | 详情 | 详情 | |
(IV) | 13881 | methyl (2S)-4-(acetylimino)-2-benzyl-2,3-dihydro-4H-chromene-6-carboxylate | C20H19NO4 | 详情 | 详情 | |
(V) | 13882 | methyl (2S)-2-benzyl-4-oxo-3,4-dihydro-2H-chromene-6-carboxylate | C18H16O4 | 详情 | 详情 | |
(VI) | 13883 | (2R)-2-Benzyl-3,4-dihydro-2H-chromene-6-carbaldehyde | C17H16O2 | 详情 | 详情 | |
(VII) | 13884 | ethyl 2-chromanecarboxylate | C12H14O3 | 详情 | 详情 | |
(VIII) | 13886 | (2R)-3,4-dihydro-2H-chromen-2-ylmethyl trifluoromethanesulfonate | C11H11F3O4S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)D-Phenylalanine (I) was protected as the methyl carbamate (II) by acylation with methyl chloroformate under Schotten-Baumann conditions. The N-methoxy amide (III) was then prepared by coupling of (II) with O-methyl hydroxylamine in the presence of EDC. Cyclization of (III) to the N-methoxy quinolinone (IV) was accomplished by treatment with bis(trifluoroacetoxy)iodobenzene in the presence of trifluoroacetic acid. Simultaneous reduction of the N-methoxy lactam and carbamate functions of (IV) by means of borane-methyl sulfide complex provided diamine (V). The aliphatic amino group of (V) was then selectively protected as the benzyl carbamate (VI) by using N-(benzyloxycarbonyloxy)succinimide at -40 C. Reaction of (VI) with phosgene, followed by treatment of the intermediate carbamoyl chloride with O-methyl hydroxylamine gave rise to the N-methoxy urea derivative (VII). This was cyclized with bis(trifluoroacetoxy)iodobenzene to the imidazoquinolinone (VIII). The N-methoxy and N-benzyloxycarbonyl groups of (VIII) were then removed by hydrogenolysis in the presence of Pearlman's catalyst, and the title compound was finally converted to the corresponding maleate salt.
【1】 Romero, A.G.; et al.; Synthesis of the selective D2 receptor agonist PNU-95666E from D-phenylalanine using a sequential oxidative cyclization strategy. J Org Chem 1997, 62, 19, 6582. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11703 | D-Phenylalanine; (R)-Phenylalanine | 673-06-3 | C9H11NO2 | 详情 | 详情 |
(II) | 55860 | (2R)-2-[(methoxycarbonyl)amino]-3-phenylpropanoic acid | C11H13NO4 | 详情 | 详情 | |
(III) | 55861 | methyl (1R)-1-benzyl-2-(methoxyamino)-2-oxoethylcarbamate | C12H16N2O4 | 详情 | 详情 | |
(IV) | 55862 | methyl (3R)-1-methoxy-2-oxo-1,2,3,4-tetrahydro-3-quinolinylcarbamate | C12H14N2O4 | 详情 | 详情 | |
(V) | 55863 | N-methyl-N-[(3R)-1,2,3,4-tetrahydro-3-quinolinyl]amine; (3R)-N-methyl-1,2,3,4-tetrahydro-3-quinolinamine | C10H14N2 | 详情 | 详情 | |
(VI) | 55864 | benzyl methyl[(3R)-1,2,3,4-tetrahydro-3-quinolinyl]carbamate | C18H20N2O2 | 详情 | 详情 | |
(VII) | 55865 | benzyl (3R)-1-[(methoxyamino)carbonyl]-1,2,3,4-tetrahydro-3-quinolinyl(methyl)carbamate | C20H23N3O4 | 详情 | 详情 | |
(VIII) | 55866 | benzyl (5R)-1-methoxy-2-oxo-1,2,5,6-tetrahydro-4H-imidazo[4,5,1-ij]quinolin-5-yl(methyl)carbamate | C20H21N3O4 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(III)
【1】 Chen SN, Feng QJ, Yu YM, et aL 2007. Preparation of H type nateglinide crystal.发明专利申请公开说明书.CN 1887858 (Hangzhou Pollen Co, Ltd, Peop Rep China) |
【2】 Wang D, Liang YH, Gang P,et aL 2002.A new synthesis method of nateglinide as antidiabetic drug. 中国药物化学杂志,12 (2): 94~96 |
【3】 Yahalomi R 2004. Process for preparing nateglirude and intermediates thereof. W0 2004005240[本专利为Teva Pharmaceutical Industries Ltd (IL)-所有] |
【4】 Zhu XY, Peng K, Wang XQ, et aL 2001. Synthesis of nateglinide.合成化学,9(6): 537~540 |